Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis

Purpose: While the occurrence of colitis during immune checkpoint inhibitor (ICI) treatment is recognized as a sign of robust immune activation and correlates with better oncological outcomes, the long-term impact of ICI-mediated colitis on the colonic mucosa has not been studied. We thus aim to des...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Antonio Pizuorno, Shatila, Malek, De Toni, Enrico N., Török, Helga-Paula, Philpott, Jessica, Zhao, Dan, Zhou, Yan, Varatharajalu, Krishnavathana, Shafi, Mehnaz A., Zhang, Hao Chi, Thomas, Anusha S., Wang, Yinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539391/
https://www.ncbi.nlm.nih.gov/pubmed/37779873
http://dx.doi.org/10.7150/jca.86635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539391/
https://www.ncbi.nlm.nih.gov/pubmed/37779873
http://dx.doi.org/10.7150/jca.86635

Ejemplares similares